Ariceum Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Berlin
Industry:BiotechHealth servicesPharma
Business model:B2B
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 51.67M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Ariceum Therapeutics
Name | Criteria | |
---|---|---|
![]() |
NMD Pharma
70%
|
|
![]() |
Sanifit Therapeutics
70%
|
|
![]() |
Synklino
70%
|
|
![]() |
Cytoki Pharma
70%
|
|
![]() |
Causaly
70%
|
|
![]() |
Cardior Pharmaceuticals
70%
|
|
![]() |
PetMedix
70%
|
|
![]() |
Emergence Therapeutics
70%
|
|
![]() |
Precirix
70%
|
|
![]() |
Kither Biotech
70%
|
|